First Isolation of a Carbapenem-Hydrolyzing β-Lactamase in Pseudomonas aeruginosa in Spain
Open Access
- 1 March 2002
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (3) , 932-933
- https://doi.org/10.1128/aac.46.3.932-933.2002
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Metallo-β-Lactamases in Clinical Pseudomonas Isolates in Taiwan and Identification of VIM-3, a Novel Variant of the VIM-2 EnzymeAntimicrobial Agents and Chemotherapy, 2001
- Plasmid-Encoded Metallo-β-Lactamase (IMP-6) Conferring Resistance to Carbapenems, Especially MeropenemAntimicrobial Agents and Chemotherapy, 2001
- Characterization of Class 1 Integrons from Pseudomonas aeruginosa That Contain the bla VIM-2 Carbapenem-Hydrolyzing β-Lactamase Gene and of Two Novel Aminoglycoside Resistance Gene CassettesAntimicrobial Agents and Chemotherapy, 2001
- Molecular heterogeneity ofblaVIM-2-containing integrons fromPseudomonas aeruginosaplasmids encoding the VIM-2 metallo-β-lactamaseFEMS Microbiology Letters, 2001
- Carbapenem-hydrolysing VIM-2 metallo- beta-lactamase in Pseudomonas aeruginosa from GreeceJournal of Antimicrobial Chemotherapy, 2000
- Hospital Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa Producing VIM-1, a Novel Transferable Metallo- -LactamaseClinical Infectious Diseases, 2000
- Carbapenemases: a problem in waiting?Current Opinion in Microbiology, 2000
- Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in FranceAntimicrobial Agents and Chemotherapy, 2000
- Cloning and Characterization of bla VIM , a New Integron-Borne Metallo-β-Lactamase Gene from a Pseudomonas aeruginosa Clinical IsolateAntimicrobial Agents and Chemotherapy, 1999